scholarly journals Cost/Effectiveness Analysis of Direct-Acting Antivirals for Hepatitis C Virus in Treatment-Naive Genotype 1 without Cirrhosis Patients in Spanish Population

2018 ◽  
Vol 21 ◽  
pp. S85 ◽  
Author(s):  
L Margusino-Framiñán ◽  
A Castro-Iglesias ◽  
A Mena-de-Cea ◽  
P Cid-Silva ◽  
I Rodriguez-Osorio ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Spanish Population ◽  
Genotype 1 ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Treatment Naïve ◽  
Direct Acting

scholarly journals A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan

2019 ◽  
Vol 37 (1) ◽  
pp. 457-476 ◽  
Author(s):  
Isao Kawaguchi ◽  
Kazuaki Chayama ◽  
Yuri Sanchez Gonzalez ◽  
Suchin Virabhak ◽  
Dominic Mitchell ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Direct Acting

Cost-effectiveness analysis of hepatitis C virus in the Spanish population who was born between 1956 and 1970

2017 ◽  
Vol 66 (1) ◽  
pp. S717-S718
Author(s):  
M. Buti ◽  
R. Domínguez-Hernández ◽  
M.A. Casado ◽  
E. Sabater ◽  
R. Esteban
Keyword(s):  
Hepatitis C Virus ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Spanish Population ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document